Other OTC Pharmaceuticals (Pharmacies) - Americas

  • Americas
  • Revenue in the Other OTC Pharmaceuticals market is projected to reach US$7.70bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.09%, resulting in a market volume of US$8.13bn by 2029.
  • In global comparison, most revenue will be generated in the United States (US$4,981.00m in 2024).
  • In relation to total population figures, per person revenues of US$7.57 are generated in 2024.

Key regions: France, Australia, India, South Korea, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals (Pharmacies) market in Americas is experiencing significant growth and development due to several key factors. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to the positive trajectory of this market. Customer preferences play a crucial role in driving the growth of the Other OTC Pharmaceuticals (Pharmacies) market in Americas. Consumers in this region are increasingly seeking convenience and accessibility when it comes to purchasing healthcare products. They prefer to have easy access to a wide range of over-the-counter medications and healthcare products, which can be conveniently found in pharmacies. Additionally, customers are becoming more health-conscious and proactive in managing their own health, leading to increased demand for OTC pharmaceuticals. Trends in the market further contribute to the development of the Other OTC Pharmaceuticals (Pharmacies) market in Americas. One notable trend is the growing popularity of online pharmacies. With the advancement of technology and the increasing use of e-commerce platforms, consumers now have the option to purchase OTC pharmaceuticals online, providing them with greater convenience and accessibility. This trend is particularly prevalent in urban areas where consumers have busy lifestyles and limited time for in-store shopping. Local special circumstances also play a role in shaping the Other OTC Pharmaceuticals (Pharmacies) market in Americas. Different countries within the region have varying regulations and healthcare systems, which can impact the availability and accessibility of OTC pharmaceuticals. Some countries may have more stringent regulations, requiring certain medications to be dispensed only by licensed pharmacists, while others may have more relaxed regulations, allowing OTC pharmaceuticals to be sold in various retail outlets. These local circumstances influence the distribution channels and market dynamics within each country. Underlying macroeconomic factors also contribute to the growth of the Other OTC Pharmaceuticals (Pharmacies) market in Americas. The region's overall economic stability and increasing disposable income levels enable consumers to spend more on healthcare products, including OTC pharmaceuticals. As the economy continues to grow, consumers are likely to prioritize their health and well-being, leading to increased demand for OTC pharmaceuticals. In conclusion, the Other OTC Pharmaceuticals (Pharmacies) market in Americas is developing and thriving due to customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. Consumers' desire for convenience and accessibility, along with the growing popularity of online pharmacies, are driving the growth of this market. Additionally, varying regulations and healthcare systems within the region, as well as the overall economic stability, contribute to the positive trajectory of the Other OTC Pharmaceuticals (Pharmacies) market in Americas.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)